ImmunoGen, Inc.
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase…
Biotechnology
US, Waltham [HQ]
Growth Rates · Payout · Yield
Dividends Over Time
Growth Rates · Payout · YieldSearching for a Dividend Aristocrat? Sign Up to view the entire dividend history of ImmunoGen, Inc.
Growth Rates
0.00%
YoY
0.00%
3Yr
0.00%
5Yr
0.00%
10Yr
Key Metrics
- -%
TTM Yield
- -
Average Days Gap
Series
- -%
Yield
0.00%
Payout Ratio
History
We could not find any dividend history for ImmunoGen, Inc..